A randomised, multicentre, double-blind, placebo controlled study of the symptomatic efficacy and safety of diacerein 100 mg/day in patients with painful hand osteoarthritis. A 16-week, prospective study with a 12-week treatment-free follow-up

Trial Profile

A randomised, multicentre, double-blind, placebo controlled study of the symptomatic efficacy and safety of diacerein 100 mg/day in patients with painful hand osteoarthritis. A 16-week, prospective study with a 12-week treatment-free follow-up

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Diacerein (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top